Guoqing Cao

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9

Holly E. Careskey, Roslyn Davis, William E. Alborn et al. · Journal of Lipid Research · 2007 · 311 citations · Full text

Veterinary Medicine, Biochemistry, Pharmacology +7

Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis

Guoqing Cao, Liang Yu, Carol L. Broderick et al. · Journal of Biological Chemistry · 2003 · 293 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol

Greg Welder, Issam Zineh, Michael Pacanowski et al. · Journal of Lipid Research · 2010 · 246 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Impaired de Novo Choline Synthesis Explains Why Phosphatidylethanolamine N-Methyltransferase-deficient Mice Are Protected from Diet-induced Obesity

René L. Jacobs, Yang Zhao, Debby P.Y. Koonen et al. · Journal of Biological Chemistry · 2010 · 215 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans

Lena Persson, Guoqing Cao, Lars Ståhle et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 171 citations · Full text

Life Sciences, Biochemistry, Physiology +17